Health and economic consequences of substance abuse. Substance use is a significant public health issue in the U.S. Over 57.8 million Americans aged 12 or older binge drink and 19.9 million individuals aged 12 or older use illicit drugs. Nearly one-fourth of Americans smoke cigarettes, and cigarette smoking remains the leading preventable cause of morbidity and mortality in the U.S(2) Over 22.3 million Americans meet criteria for a SUD Substance use among youth also remains a major public health problem. According to the schoolbased. Monitoring the Future study , almost half (47%) of all 12 graders have tried an illicit drug in their lifetime. Cannabis is the most prevalent illicit psychoactive substance used by adolescents in the U.S.(2) with 43% of 12th graders reporting marijuana use. Additionally, 72% of youth in this age group have used alcohol, and over 55% have been drunk. Approximately 45% of this group has used cigarettes. Further, rates of nonmedical use of prescripfion opioids among youth have markedly increased in the recent past (e.g., 1 in ten 12th graders report non-medical use of Vicodin in the past year)(3). Substance use results in numerous, significant social, medical, psychological, and economic consequences and is associated with marked productivity losses, criminality, and health care costs, including illness and infectious diseases, such as HIV and hepatifis. Approximately one in five deaths in the U.S. (more than one-half million persons each year) is a result of substance use(4). Recent esfimates indicate that the cost of SUDs in the U.S. is over one-half trillion dollars(5).

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA029926-04
Application #
8657021
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
4
Fiscal Year
2014
Total Cost
$341,870
Indirect Cost
$107,045
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Beckham, Jean C; Adkisson, Kelsie A; Hertzberg, Jeffrey et al. (2018) Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking. Addict Behav 79:86-92
Stoianova, Maria; Tampke, Elizabeth C; Lansing, Amy Hughes et al. (2018) Delay discounting associated with challenges to treatment adherence and glycemic control in young adults with type 1 diabetes. Behav Processes 157:474-477
Duncan, Lindsay R; Hieftje, Kimberly D; Pendergrass, Tyra M et al. (2018) Preliminary investigation of a videogame prototype for cigarette and marijuana prevention in adolescents. Subst Abus :1-5
Aschbrenner, Kelly A; Patten, Christi A; Brunette, Mary F (2018) Feasibility of a support person intervention to promote smoking cessation treatment use among smokers with mental illness. Transl Behav Med 8:785-792
Borodovsky, Jacob T; Levy, Sharon; Fishman, Marc et al. (2018) Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review. J Addict Med 12:170-183
Naslund, John A; Aschbrenner, Kelly A; Marsch, Lisa A et al. (2018) Facebook for Supporting a Lifestyle Intervention for People with Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: an Exploratory Study. Psychiatr Q 89:81-94
Marsch, Lisa A (2018) Opportunities and needs in digital phenotyping. Neuropsychopharmacology 43:1637-1638
Aschbrenner, Kelly A; Naslund, John A; Grinley, Thomas et al. (2018) A Survey of Online and Mobile Technology Use at Peer Support Agencies. Psychiatr Q 89:539-548
Schuman-Olivier, Zev; Borodovsky, Jacob T; Steinkamp, Jackson et al. (2018) MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study. Addict Sci Clin Pract 13:21
Gabrielli, Joy; Marsch, Lisa; Tanski, Susanne (2018) TECH Parenting to Promote Effective Media Management. Pediatrics 142:

Showing the most recent 10 out of 121 publications